Advances in genetics research.: Vol. 7 /
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Nova Science Publishers, Inc.,
©2012.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | "Nova biomedical." Title from PDF title page (viewed March 27, 2013). |
| Beschreibung: | 1 online resource : illustrations |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781614700296 161470029X |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn832709516 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 130327s2012 nyua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d YDXCP |d OCLCF |d OCLCQ |d VTS |d AU@ |d STF |d OCLCQ |d K6U |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
| 020 | |a 9781614700296 |q (electronic bk.) | ||
| 020 | |a 161470029X |q (electronic bk.) | ||
| 035 | |a (OCoLC)832709516 | ||
| 050 | 4 | |a QH430 | |
| 072 | 7 | |a SCI |x 029000 |2 bisacsh | |
| 082 | 7 | |a 576.5 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Advances in genetics research. |p Vol. 7 / |c Kevin V. Urbano, editor. |
| 260 | |a New York : |b Nova Science Publishers, Inc., |c ©2012. | ||
| 300 | |a 1 online resource : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a "Nova biomedical." | ||
| 504 | |a Includes bibliographical references and index. | ||
| 500 | |a Title from PDF title page (viewed March 27, 2013). | ||
| 505 | 0 | |a ADVANCES INGENETICS RESEARCHVOLUME 7; ADVANCES IN GENETICS RESEARCH; Library of Congress Cataloging-in-Publication Data; Contents; Preface; List of Contributors; Gene Therapy for HepatocyteGrowth Factor Supplementationin the Rescue of IncurableOrgan Diseases; Abstract; 1. Introduction; 2. HGF and its Biological Property; 2.1. Effect of HGF on Parenchymal Cells; 2.2. Anti-Fibrotic Activity of HGF; 2.3. Anti-Inflammatory Action of HGF toward Macrophages; 2.4. Angiogenic Action of HGF toward Vascular Cells; 3. HGF-Deficiency as a PahtogeneticSignificance; 3.1. Kidney; 3.2. Liver and Lungs. | |
| 505 | 8 | |a 3.3. Other Organs4. Supplement therapy with RecombinantHGF Protein; 4.1. Acute Diseases; 4.2. Fibrotic Diseases; 4.3. Cardiovascular and Neural Diseases; 5. HGF Gene Therapy for Fibrotic and Obstructive Diseases; 5.1. Fibrotic Diseases; 5.2. Chronic Obstructive Pulmonary Disease (COPD); 5.3. Peripheral Artery Disease (PAD); 6. HGF Gene Drug for Treating Cardiacand Neural Diseases; 6.1. Heart Diseases; 6.1.1. Chronic Myocardial Infarction (MI); 6.1.2. Dilatative Cardiomyopathy; 6.2. Neural Diseases; 6.2.1. Chronic Cerebral Infarction (CI); 6.2.2. Neuro-Degenerative Diseases. | |
| 505 | 8 | |a 6.2.3. Spinal Cord Injury (SCI)6.2.4. Other Neural Diseases; 7. Other Applications for HGFGene Therapy; 7.1. Diabetes Mellitus (DM) and its Complications; 7.2. Inflammatory Bowel Diseases (IBD); 7.3. Organ Transplantation; 7.4. Others; 8. Vector and New Device for SupportingHGF Gene Therapy; 8.1. Non-Viral Vectors; 8.2. Virus Vectors; 8.3. Gene Carrier; 8.4. New Device; 9. Clinical Studies and Future Perspective; References; Targeting Bacteriocin Genes inLactic Acid Bacteria -- What WeNeed To Know; Abstract; Introduction; Bacteriocin Genes Reported in LacticAcid Bacteria. | |
| 505 | 8 | |a Bacteriocin Detected by PCR and Confirmed Expression by otherApproachesConclusions; References; Nanomedicine Based Strategiesfor RNA Therapeutics; Abstract; Introduction; Basic Principle and Mechanism of RNA Interference; Advantages and Limits of Nanoparticles; Barriers to siRNA Delivery; In Vitro Barriers; In Vivo Barriers; Strategies for Targeted siRNA Delivery; Peptides; Transferrin; Antibodies; Targeting Ligands; Delivery of siRNA with PolycationicVectors; Polyethylenimine; Chitosan; Poly-L-Lysine; Cyclodextrin; Protamine; Encapsulation of siRNA withinNanoparticles; Future Perspectives. | |
| 650 | 0 | |a Genetics |x Research. |0 http://id.loc.gov/authorities/subjects/sh85053880 | |
| 650 | 7 | |a SCIENCE |x Life Sciences |x Genetics & Genomics. |2 bisacsh | |
| 650 | 7 | |a Genetics |x Research |2 fast | |
| 700 | 1 | |a Urbano, Kevin V. | |
| 758 | |i has work: |a Advances in genetics research Volume 7 (Text) |1 https://id.oclc.org/worldcat/entity/E39PCXYWQJrhBW4V6dP8JH9Mj3 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540129 |3 Volltext |
| 938 | |a EBSCOhost |b EBSC |n 540129 | ||
| 938 | |a YBP Library Services |b YANK |n 4995136 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn832709516 |
|---|---|
| _version_ | 1816882226462195712 |
| adam_text | |
| any_adam_object | |
| author2 | Urbano, Kevin V. |
| author2_role | |
| author2_variant | k v u kv kvu |
| author_facet | Urbano, Kevin V. |
| author_sort | Urbano, Kevin V. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | Q - Science |
| callnumber-label | QH430 |
| callnumber-raw | QH430 |
| callnumber-search | QH430 |
| callnumber-sort | QH 3430 |
| callnumber-subject | QH - Natural History and Biology |
| collection | ZDB-4-EBA |
| contents | ADVANCES INGENETICS RESEARCHVOLUME 7; ADVANCES IN GENETICS RESEARCH; Library of Congress Cataloging-in-Publication Data; Contents; Preface; List of Contributors; Gene Therapy for HepatocyteGrowth Factor Supplementationin the Rescue of IncurableOrgan Diseases; Abstract; 1. Introduction; 2. HGF and its Biological Property; 2.1. Effect of HGF on Parenchymal Cells; 2.2. Anti-Fibrotic Activity of HGF; 2.3. Anti-Inflammatory Action of HGF toward Macrophages; 2.4. Angiogenic Action of HGF toward Vascular Cells; 3. HGF-Deficiency as a PahtogeneticSignificance; 3.1. Kidney; 3.2. Liver and Lungs. 3.3. Other Organs4. Supplement therapy with RecombinantHGF Protein; 4.1. Acute Diseases; 4.2. Fibrotic Diseases; 4.3. Cardiovascular and Neural Diseases; 5. HGF Gene Therapy for Fibrotic and Obstructive Diseases; 5.1. Fibrotic Diseases; 5.2. Chronic Obstructive Pulmonary Disease (COPD); 5.3. Peripheral Artery Disease (PAD); 6. HGF Gene Drug for Treating Cardiacand Neural Diseases; 6.1. Heart Diseases; 6.1.1. Chronic Myocardial Infarction (MI); 6.1.2. Dilatative Cardiomyopathy; 6.2. Neural Diseases; 6.2.1. Chronic Cerebral Infarction (CI); 6.2.2. Neuro-Degenerative Diseases. 6.2.3. Spinal Cord Injury (SCI)6.2.4. Other Neural Diseases; 7. Other Applications for HGFGene Therapy; 7.1. Diabetes Mellitus (DM) and its Complications; 7.2. Inflammatory Bowel Diseases (IBD); 7.3. Organ Transplantation; 7.4. Others; 8. Vector and New Device for SupportingHGF Gene Therapy; 8.1. Non-Viral Vectors; 8.2. Virus Vectors; 8.3. Gene Carrier; 8.4. New Device; 9. Clinical Studies and Future Perspective; References; Targeting Bacteriocin Genes inLactic Acid Bacteria -- What WeNeed To Know; Abstract; Introduction; Bacteriocin Genes Reported in LacticAcid Bacteria. Bacteriocin Detected by PCR and Confirmed Expression by otherApproachesConclusions; References; Nanomedicine Based Strategiesfor RNA Therapeutics; Abstract; Introduction; Basic Principle and Mechanism of RNA Interference; Advantages and Limits of Nanoparticles; Barriers to siRNA Delivery; In Vitro Barriers; In Vivo Barriers; Strategies for Targeted siRNA Delivery; Peptides; Transferrin; Antibodies; Targeting Ligands; Delivery of siRNA with PolycationicVectors; Polyethylenimine; Chitosan; Poly-L-Lysine; Cyclodextrin; Protamine; Encapsulation of siRNA withinNanoparticles; Future Perspectives. |
| ctrlnum | (OCoLC)832709516 |
| dewey-full | 576.5 |
| dewey-hundreds | 500 - Natural sciences and mathematics |
| dewey-ones | 576 - Genetics and evolution |
| dewey-raw | 576.5 |
| dewey-search | 576.5 |
| dewey-sort | 3576.5 |
| dewey-tens | 570 - Biology |
| discipline | Biologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04096cam a2200457 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn832709516</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">130327s2012 nyua ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">AU@</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781614700296</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">161470029X</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)832709516</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QH430</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">SCI</subfield><subfield code="x">029000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">576.5</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Advances in genetics research.</subfield><subfield code="p">Vol. 7 /</subfield><subfield code="c">Kevin V. Urbano, editor.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">New York :</subfield><subfield code="b">Nova Science Publishers, Inc.,</subfield><subfield code="c">©2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Nova biomedical."</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from PDF title page (viewed March 27, 2013).</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">ADVANCES INGENETICS RESEARCHVOLUME 7; ADVANCES IN GENETICS RESEARCH; Library of Congress Cataloging-in-Publication Data; Contents; Preface; List of Contributors; Gene Therapy for HepatocyteGrowth Factor Supplementationin the Rescue of IncurableOrgan Diseases; Abstract; 1. Introduction; 2. HGF and its Biological Property; 2.1. Effect of HGF on Parenchymal Cells; 2.2. Anti-Fibrotic Activity of HGF; 2.3. Anti-Inflammatory Action of HGF toward Macrophages; 2.4. Angiogenic Action of HGF toward Vascular Cells; 3. HGF-Deficiency as a PahtogeneticSignificance; 3.1. Kidney; 3.2. Liver and Lungs.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3.3. Other Organs4. Supplement therapy with RecombinantHGF Protein; 4.1. Acute Diseases; 4.2. Fibrotic Diseases; 4.3. Cardiovascular and Neural Diseases; 5. HGF Gene Therapy for Fibrotic and Obstructive Diseases; 5.1. Fibrotic Diseases; 5.2. Chronic Obstructive Pulmonary Disease (COPD); 5.3. Peripheral Artery Disease (PAD); 6. HGF Gene Drug for Treating Cardiacand Neural Diseases; 6.1. Heart Diseases; 6.1.1. Chronic Myocardial Infarction (MI); 6.1.2. Dilatative Cardiomyopathy; 6.2. Neural Diseases; 6.2.1. Chronic Cerebral Infarction (CI); 6.2.2. Neuro-Degenerative Diseases.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">6.2.3. Spinal Cord Injury (SCI)6.2.4. Other Neural Diseases; 7. Other Applications for HGFGene Therapy; 7.1. Diabetes Mellitus (DM) and its Complications; 7.2. Inflammatory Bowel Diseases (IBD); 7.3. Organ Transplantation; 7.4. Others; 8. Vector and New Device for SupportingHGF Gene Therapy; 8.1. Non-Viral Vectors; 8.2. Virus Vectors; 8.3. Gene Carrier; 8.4. New Device; 9. Clinical Studies and Future Perspective; References; Targeting Bacteriocin Genes inLactic Acid Bacteria -- What WeNeed To Know; Abstract; Introduction; Bacteriocin Genes Reported in LacticAcid Bacteria.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Bacteriocin Detected by PCR and Confirmed Expression by otherApproachesConclusions; References; Nanomedicine Based Strategiesfor RNA Therapeutics; Abstract; Introduction; Basic Principle and Mechanism of RNA Interference; Advantages and Limits of Nanoparticles; Barriers to siRNA Delivery; In Vitro Barriers; In Vivo Barriers; Strategies for Targeted siRNA Delivery; Peptides; Transferrin; Antibodies; Targeting Ligands; Delivery of siRNA with PolycationicVectors; Polyethylenimine; Chitosan; Poly-L-Lysine; Cyclodextrin; Protamine; Encapsulation of siRNA withinNanoparticles; Future Perspectives.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Genetics</subfield><subfield code="x">Research.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85053880</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SCIENCE</subfield><subfield code="x">Life Sciences</subfield><subfield code="x">Genetics & Genomics.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genetics</subfield><subfield code="x">Research</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Urbano, Kevin V.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Advances in genetics research Volume 7 (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCXYWQJrhBW4V6dP8JH9Mj3</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540129</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">540129</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">4995136</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn832709516 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:25:15Z |
| institution | BVB |
| isbn | 9781614700296 161470029X |
| language | English |
| oclc_num | 832709516 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | Nova Science Publishers, Inc., |
| record_format | marc |
| spelling | Advances in genetics research. Vol. 7 / Kevin V. Urbano, editor. New York : Nova Science Publishers, Inc., ©2012. 1 online resource : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier "Nova biomedical." Includes bibliographical references and index. Title from PDF title page (viewed March 27, 2013). ADVANCES INGENETICS RESEARCHVOLUME 7; ADVANCES IN GENETICS RESEARCH; Library of Congress Cataloging-in-Publication Data; Contents; Preface; List of Contributors; Gene Therapy for HepatocyteGrowth Factor Supplementationin the Rescue of IncurableOrgan Diseases; Abstract; 1. Introduction; 2. HGF and its Biological Property; 2.1. Effect of HGF on Parenchymal Cells; 2.2. Anti-Fibrotic Activity of HGF; 2.3. Anti-Inflammatory Action of HGF toward Macrophages; 2.4. Angiogenic Action of HGF toward Vascular Cells; 3. HGF-Deficiency as a PahtogeneticSignificance; 3.1. Kidney; 3.2. Liver and Lungs. 3.3. Other Organs4. Supplement therapy with RecombinantHGF Protein; 4.1. Acute Diseases; 4.2. Fibrotic Diseases; 4.3. Cardiovascular and Neural Diseases; 5. HGF Gene Therapy for Fibrotic and Obstructive Diseases; 5.1. Fibrotic Diseases; 5.2. Chronic Obstructive Pulmonary Disease (COPD); 5.3. Peripheral Artery Disease (PAD); 6. HGF Gene Drug for Treating Cardiacand Neural Diseases; 6.1. Heart Diseases; 6.1.1. Chronic Myocardial Infarction (MI); 6.1.2. Dilatative Cardiomyopathy; 6.2. Neural Diseases; 6.2.1. Chronic Cerebral Infarction (CI); 6.2.2. Neuro-Degenerative Diseases. 6.2.3. Spinal Cord Injury (SCI)6.2.4. Other Neural Diseases; 7. Other Applications for HGFGene Therapy; 7.1. Diabetes Mellitus (DM) and its Complications; 7.2. Inflammatory Bowel Diseases (IBD); 7.3. Organ Transplantation; 7.4. Others; 8. Vector and New Device for SupportingHGF Gene Therapy; 8.1. Non-Viral Vectors; 8.2. Virus Vectors; 8.3. Gene Carrier; 8.4. New Device; 9. Clinical Studies and Future Perspective; References; Targeting Bacteriocin Genes inLactic Acid Bacteria -- What WeNeed To Know; Abstract; Introduction; Bacteriocin Genes Reported in LacticAcid Bacteria. Bacteriocin Detected by PCR and Confirmed Expression by otherApproachesConclusions; References; Nanomedicine Based Strategiesfor RNA Therapeutics; Abstract; Introduction; Basic Principle and Mechanism of RNA Interference; Advantages and Limits of Nanoparticles; Barriers to siRNA Delivery; In Vitro Barriers; In Vivo Barriers; Strategies for Targeted siRNA Delivery; Peptides; Transferrin; Antibodies; Targeting Ligands; Delivery of siRNA with PolycationicVectors; Polyethylenimine; Chitosan; Poly-L-Lysine; Cyclodextrin; Protamine; Encapsulation of siRNA withinNanoparticles; Future Perspectives. Genetics Research. http://id.loc.gov/authorities/subjects/sh85053880 SCIENCE Life Sciences Genetics & Genomics. bisacsh Genetics Research fast Urbano, Kevin V. has work: Advances in genetics research Volume 7 (Text) https://id.oclc.org/worldcat/entity/E39PCXYWQJrhBW4V6dP8JH9Mj3 https://id.oclc.org/worldcat/ontology/hasWork FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540129 Volltext |
| spellingShingle | Advances in genetics research. ADVANCES INGENETICS RESEARCHVOLUME 7; ADVANCES IN GENETICS RESEARCH; Library of Congress Cataloging-in-Publication Data; Contents; Preface; List of Contributors; Gene Therapy for HepatocyteGrowth Factor Supplementationin the Rescue of IncurableOrgan Diseases; Abstract; 1. Introduction; 2. HGF and its Biological Property; 2.1. Effect of HGF on Parenchymal Cells; 2.2. Anti-Fibrotic Activity of HGF; 2.3. Anti-Inflammatory Action of HGF toward Macrophages; 2.4. Angiogenic Action of HGF toward Vascular Cells; 3. HGF-Deficiency as a PahtogeneticSignificance; 3.1. Kidney; 3.2. Liver and Lungs. 3.3. Other Organs4. Supplement therapy with RecombinantHGF Protein; 4.1. Acute Diseases; 4.2. Fibrotic Diseases; 4.3. Cardiovascular and Neural Diseases; 5. HGF Gene Therapy for Fibrotic and Obstructive Diseases; 5.1. Fibrotic Diseases; 5.2. Chronic Obstructive Pulmonary Disease (COPD); 5.3. Peripheral Artery Disease (PAD); 6. HGF Gene Drug for Treating Cardiacand Neural Diseases; 6.1. Heart Diseases; 6.1.1. Chronic Myocardial Infarction (MI); 6.1.2. Dilatative Cardiomyopathy; 6.2. Neural Diseases; 6.2.1. Chronic Cerebral Infarction (CI); 6.2.2. Neuro-Degenerative Diseases. 6.2.3. Spinal Cord Injury (SCI)6.2.4. Other Neural Diseases; 7. Other Applications for HGFGene Therapy; 7.1. Diabetes Mellitus (DM) and its Complications; 7.2. Inflammatory Bowel Diseases (IBD); 7.3. Organ Transplantation; 7.4. Others; 8. Vector and New Device for SupportingHGF Gene Therapy; 8.1. Non-Viral Vectors; 8.2. Virus Vectors; 8.3. Gene Carrier; 8.4. New Device; 9. Clinical Studies and Future Perspective; References; Targeting Bacteriocin Genes inLactic Acid Bacteria -- What WeNeed To Know; Abstract; Introduction; Bacteriocin Genes Reported in LacticAcid Bacteria. Bacteriocin Detected by PCR and Confirmed Expression by otherApproachesConclusions; References; Nanomedicine Based Strategiesfor RNA Therapeutics; Abstract; Introduction; Basic Principle and Mechanism of RNA Interference; Advantages and Limits of Nanoparticles; Barriers to siRNA Delivery; In Vitro Barriers; In Vivo Barriers; Strategies for Targeted siRNA Delivery; Peptides; Transferrin; Antibodies; Targeting Ligands; Delivery of siRNA with PolycationicVectors; Polyethylenimine; Chitosan; Poly-L-Lysine; Cyclodextrin; Protamine; Encapsulation of siRNA withinNanoparticles; Future Perspectives. Genetics Research. http://id.loc.gov/authorities/subjects/sh85053880 SCIENCE Life Sciences Genetics & Genomics. bisacsh Genetics Research fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85053880 |
| title | Advances in genetics research. |
| title_auth | Advances in genetics research. |
| title_exact_search | Advances in genetics research. |
| title_full | Advances in genetics research. Vol. 7 / Kevin V. Urbano, editor. |
| title_fullStr | Advances in genetics research. Vol. 7 / Kevin V. Urbano, editor. |
| title_full_unstemmed | Advances in genetics research. Vol. 7 / Kevin V. Urbano, editor. |
| title_short | Advances in genetics research. |
| title_sort | advances in genetics research vol 7 |
| topic | Genetics Research. http://id.loc.gov/authorities/subjects/sh85053880 SCIENCE Life Sciences Genetics & Genomics. bisacsh Genetics Research fast |
| topic_facet | Genetics Research. SCIENCE Life Sciences Genetics & Genomics. Genetics Research |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540129 |
| work_keys_str_mv | AT urbanokevinv advancesingeneticsresearch |